Take a look at the industry headlines from the last 2 months, including the FDA approval of Ebola vaccine Ervebo,…
Research has suggested that prophylactic antibiotics are overprescribed before dental visits, and that taking them could actually increase the likelihood of adverse effects.
Research published this week suggests a specific fungus is present in Clostridium difficile infections, potentially presenting a future therapeutic target.
Researchers discover Clostridium difficile is evolving due to genetic changes that allow it to thrive on the Western diet and evade disinfectants making it highly adapted to spread in hospitals.
In a study of healthy infants, researchers discover exposure to C. difficile in infancy may provide natural immunization later in childhood.
Stainless steel and surgical gowns remain contaminated with Clostridium difficile even after treatment with the recommended disinfectant, according to new research.
The US FDA has issued a safety communication regarding investigational FMT, warning that there is a risk of serious infection caused by the transfer of multidrug-resistant organisms.
New research has identified a link between the use of non-steroidal anti-inflammatory drugs – commonly used as pain relief – and more severe C. difficile infections in mouse models.
Glenn Tillotson gives us an overview of the CDiff Foundation’s 6th annual educational meeting, including updates on new C. difficile IDSA/SHEA clinical guidelines and patient perspectives.
In this interview, we spoke to Yoav Golan about recent developments in the field of Clostridium difficile infections – from the latest clinical trial results to newly updated guidelines.
